JP2006504690A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504690A5 JP2006504690A5 JP2004535749A JP2004535749A JP2006504690A5 JP 2006504690 A5 JP2006504690 A5 JP 2006504690A5 JP 2004535749 A JP2004535749 A JP 2004535749A JP 2004535749 A JP2004535749 A JP 2004535749A JP 2006504690 A5 JP2006504690 A5 JP 2006504690A5
- Authority
- JP
- Japan
- Prior art keywords
- diaza
- bicyclo
- pyridin
- phenyl
- decane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- -1 (5-bromo-pyridin-3-yl) -1,4-diaza-bicyclo [3.2.1] octane Chemical compound 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 125000006554 (C4-C8) cycloalkenyl group Chemical group 0.000 claims 3
- CZZCFUXFYKHSCR-UHFFFAOYSA-N 3-(1,4-diazabicyclo[3.2.1]octan-4-yl)quinoline Chemical compound C1=CC=CC2=CC(N3C4CN(CC3)CC4)=CN=C21 CZZCFUXFYKHSCR-UHFFFAOYSA-N 0.000 claims 3
- PZLXMKKMMUZJGW-UHFFFAOYSA-N 3-(1,4-diazabicyclo[3.3.1]nonan-4-yl)quinoline Chemical compound C1=CC=CC2=CC(N3CCN4CC3CCC4)=CN=C21 PZLXMKKMMUZJGW-UHFFFAOYSA-N 0.000 claims 3
- PAKIRKMGOXJXPJ-UHFFFAOYSA-N 4-(3-bromophenyl)-1,4-diazabicyclo[3.2.1]octane Chemical compound BrC1=CC=CC(N2C3CCN(C3)CC2)=C1 PAKIRKMGOXJXPJ-UHFFFAOYSA-N 0.000 claims 3
- RZOFBCHTTCAGOJ-UHFFFAOYSA-N 4-(3-bromophenyl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound BrC1=CC=CC(N2C3CCCN(C3)CC2)=C1 RZOFBCHTTCAGOJ-UHFFFAOYSA-N 0.000 claims 3
- GDOBURXBSBYLHW-UHFFFAOYSA-N 4-(3-bromophenyl)-1,4-diazabicyclo[3.3.2]decane Chemical compound BrC1=CC=CC(N2C3CCCN(CC3)CC2)=C1 GDOBURXBSBYLHW-UHFFFAOYSA-N 0.000 claims 3
- SKAKTVWAPJKIFF-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound N1=CC(Br)=CC=C1N1C(C2)CCCN2CC1 SKAKTVWAPJKIFF-UHFFFAOYSA-N 0.000 claims 3
- HRXDHWAFQTYSJI-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound N1=CC(Br)=CC=C1N1C(CC2)CCCN2CC1 HRXDHWAFQTYSJI-UHFFFAOYSA-N 0.000 claims 3
- ZAEYVDKQJXYNRA-UHFFFAOYSA-N 4-(5-bromopyridin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound BrC1=CN=CC(N2C3CCCN(C3)CC2)=C1 ZAEYVDKQJXYNRA-UHFFFAOYSA-N 0.000 claims 3
- FBULCFGEGXTZTF-UHFFFAOYSA-N 4-(5-bromopyridin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound BrC1=CN=CC(N2C3CCCN(CC3)CC2)=C1 FBULCFGEGXTZTF-UHFFFAOYSA-N 0.000 claims 3
- GOZFRBCNVGUKQZ-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound N1=CC(Cl)=CC=C1N1C(C2)CCN2CC1 GOZFRBCNVGUKQZ-UHFFFAOYSA-N 0.000 claims 3
- GULGZYQNYCLMGE-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound N1=CC(Cl)=CC=C1N1C(CC2)CCCN2CC1 GULGZYQNYCLMGE-UHFFFAOYSA-N 0.000 claims 3
- WRAIIFJOHGJMOG-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound ClC1=CN=CC(N2C3CCN(C3)CC2)=C1 WRAIIFJOHGJMOG-UHFFFAOYSA-N 0.000 claims 3
- OLMRKBMRQCMXCC-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound ClC1=CN=CC(N2C3CCCN(C3)CC2)=C1 OLMRKBMRQCMXCC-UHFFFAOYSA-N 0.000 claims 3
- XMXXTGPJVYOTQG-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound ClC1=CN=CC(N2C3CCCN(CC3)CC2)=C1 XMXXTGPJVYOTQG-UHFFFAOYSA-N 0.000 claims 3
- VILSVHLWVFBVRH-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound COC1=CN=CC(N2C3CCN(C3)CC2)=C1 VILSVHLWVFBVRH-UHFFFAOYSA-N 0.000 claims 3
- GEKYPDQKOYYENZ-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound COC1=CN=CC(N2C3CCCN(C3)CC2)=C1 GEKYPDQKOYYENZ-UHFFFAOYSA-N 0.000 claims 3
- LJWBVWXRRPTZIS-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound COC1=CN=CC(N2C3CCCN(CC3)CC2)=C1 LJWBVWXRRPTZIS-UHFFFAOYSA-N 0.000 claims 3
- GRHSJEMXXKQNDA-UHFFFAOYSA-N 4-(5-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C(N=NC=1)=CC=1C1=CC=CC=C1 GRHSJEMXXKQNDA-UHFFFAOYSA-N 0.000 claims 3
- JYQOMKIANCALIC-UHFFFAOYSA-N 4-(5-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C(N=NC=1)=CC=1C1=CC=CC=C1 JYQOMKIANCALIC-UHFFFAOYSA-N 0.000 claims 3
- UAAHGEQBWIXENF-UHFFFAOYSA-N 4-(5-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C(N=NC=1)=CC=1C1=CC=CC=C1 UAAHGEQBWIXENF-UHFFFAOYSA-N 0.000 claims 3
- GVDPDUFGZDFRIT-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C(C=1)=CN=CC=1C1=CC=CC=C1 GVDPDUFGZDFRIT-UHFFFAOYSA-N 0.000 claims 3
- LISJKWUCPNWEOC-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C(C=1)=CN=CC=1C1=CC=CC=C1 LISJKWUCPNWEOC-UHFFFAOYSA-N 0.000 claims 3
- HMRNFWXWPOKOJT-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound COC1=CC=CC(N2C3CCN(C3)CC2)=N1 HMRNFWXWPOKOJT-UHFFFAOYSA-N 0.000 claims 3
- QNESBMMNVFEIPH-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound COC1=CC=CC(N2C3CCCN(C3)CC2)=N1 QNESBMMNVFEIPH-UHFFFAOYSA-N 0.000 claims 3
- PKPKKSFSJOKEJY-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound COC1=CC=CC(N2C3CCCN(CC3)CC2)=N1 PKPKKSFSJOKEJY-UHFFFAOYSA-N 0.000 claims 3
- XQAWFXFXLGDFBI-UHFFFAOYSA-N 4-(6-methylpyridin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=NC(C)=CC=C1N1C(C2)CCN2CC1 XQAWFXFXLGDFBI-UHFFFAOYSA-N 0.000 claims 3
- CTBCKNFETQBXOR-UHFFFAOYSA-N 4-(6-methylpyridin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=NC(C)=CC=C1N1C(C2)CCCN2CC1 CTBCKNFETQBXOR-UHFFFAOYSA-N 0.000 claims 3
- QFJTUXBLRBWTEJ-UHFFFAOYSA-N 4-(6-methylpyridin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=NC(C)=CC=C1N1C(CC2)CCCN2CC1 QFJTUXBLRBWTEJ-UHFFFAOYSA-N 0.000 claims 3
- VXERHFMAUHEXOE-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C(N=N1)=CC=C1C1=CC=CC=C1 VXERHFMAUHEXOE-UHFFFAOYSA-N 0.000 claims 3
- FMLGWRTUSSURJM-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C(N=N1)=CC=C1C1=CC=CC=C1 FMLGWRTUSSURJM-UHFFFAOYSA-N 0.000 claims 3
- REGSTBYCKNWZFL-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C(N=N1)=CC=C1C1=CC=CC=C1 REGSTBYCKNWZFL-UHFFFAOYSA-N 0.000 claims 3
- GBTRBLAHLCTJDQ-UHFFFAOYSA-N 4-[2-methyl-5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound CC1=NC=C(C(F)(F)F)C=C1N1C(C2)CCCN2CC1 GBTRBLAHLCTJDQ-UHFFFAOYSA-N 0.000 claims 3
- GSCSOEMPXNZDHB-UHFFFAOYSA-N 4-[3-(trifluoromethyl)pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC(F)(F)C1=CC=CN=C1N1C(C2)CCN2CC1 GSCSOEMPXNZDHB-UHFFFAOYSA-N 0.000 claims 3
- GQKWBHVDNMGZDG-UHFFFAOYSA-N 4-[3-(trifluoromethyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC(F)(F)C1=CC=CN=C1N1C(CC2)CCCN2CC1 GQKWBHVDNMGZDG-UHFFFAOYSA-N 0.000 claims 3
- HUUQVDMXFJWIFG-UHFFFAOYSA-N 4-[5-(2,4-dichlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound ClC1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 HUUQVDMXFJWIFG-UHFFFAOYSA-N 0.000 claims 3
- PSRVJROVCNRGDD-UHFFFAOYSA-N 4-[5-(2,4-dichlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound ClC1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 PSRVJROVCNRGDD-UHFFFAOYSA-N 0.000 claims 3
- JWLYIHFOXTXJLT-UHFFFAOYSA-N 4-[5-(2,4-dichlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound ClC1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 JWLYIHFOXTXJLT-UHFFFAOYSA-N 0.000 claims 3
- DOWIGBPKOCELEM-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 DOWIGBPKOCELEM-UHFFFAOYSA-N 0.000 claims 3
- PRGQZMAPNBHVTO-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 PRGQZMAPNBHVTO-UHFFFAOYSA-N 0.000 claims 3
- YRXCFAOQHQRJKQ-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 YRXCFAOQHQRJKQ-UHFFFAOYSA-N 0.000 claims 3
- GIPKYCKNDKUZIJ-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 GIPKYCKNDKUZIJ-UHFFFAOYSA-N 0.000 claims 3
- CLAJZAITPOWRSR-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 CLAJZAITPOWRSR-UHFFFAOYSA-N 0.000 claims 3
- CZYIWVGHQDJXMU-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 CZYIWVGHQDJXMU-UHFFFAOYSA-N 0.000 claims 3
- BIRJSUWWHHMYQV-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound CC1=CC=CC=C1C1=CC=C(N2C3CCN(C3)CC2)N=C1 BIRJSUWWHHMYQV-UHFFFAOYSA-N 0.000 claims 3
- FIPBHJQOBJCWDX-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound CC1=CC=CC=C1C1=CC=C(N2C3CCCN(C3)CC2)N=C1 FIPBHJQOBJCWDX-UHFFFAOYSA-N 0.000 claims 3
- ZUZDHQAUCVXXEC-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound CC1=CC=CC=C1C1=CC=C(N2C3CCCN(CC3)CC2)N=C1 ZUZDHQAUCVXXEC-UHFFFAOYSA-N 0.000 claims 3
- RULOXOPFFKXVRW-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound CC1=CC=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 RULOXOPFFKXVRW-UHFFFAOYSA-N 0.000 claims 3
- WVIRFUXCBFMHBB-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound CC1=CC=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 WVIRFUXCBFMHBB-UHFFFAOYSA-N 0.000 claims 3
- DPFGXFYAPOQRBA-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound CC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 DPFGXFYAPOQRBA-UHFFFAOYSA-N 0.000 claims 3
- PHCGMSZMSRENMQ-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound ClC1=CC=CC(C=2C=NC(=CC=2)N2C3CCN(C3)CC2)=C1 PHCGMSZMSRENMQ-UHFFFAOYSA-N 0.000 claims 3
- TVTFWHNURZHZOA-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound ClC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CC3)CC2)=C1 TVTFWHNURZHZOA-UHFFFAOYSA-N 0.000 claims 3
- LOZAXNVJUXOXKM-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound ClC1=CC=CC(C=2C=C(C=NC=2)N2C3CCN(C3)CC2)=C1 LOZAXNVJUXOXKM-UHFFFAOYSA-N 0.000 claims 3
- UZUBGVRWZKGHGY-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound ClC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(C3)CC2)=C1 UZUBGVRWZKGHGY-UHFFFAOYSA-N 0.000 claims 3
- OWEDYSYZJDEVOH-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound ClC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CC3)CC2)=C1 OWEDYSYZJDEVOH-UHFFFAOYSA-N 0.000 claims 3
- VWGICUSWTVBFJS-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC1=CC=CC(C=2C=NC(=CC=2)N2C3CCN(C3)CC2)=C1 VWGICUSWTVBFJS-UHFFFAOYSA-N 0.000 claims 3
- BDEPCXUCJDOPEX-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(C3)CC2)=C1 BDEPCXUCJDOPEX-UHFFFAOYSA-N 0.000 claims 3
- NWQBKZPHCONCJD-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CC3)CC2)=C1 NWQBKZPHCONCJD-UHFFFAOYSA-N 0.000 claims 3
- SGYKUBRQFGDPGE-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CCN(C3)CC2)=C1 SGYKUBRQFGDPGE-UHFFFAOYSA-N 0.000 claims 3
- PZEQKMGBTHWMCG-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(C3)CC2)=C1 PZEQKMGBTHWMCG-UHFFFAOYSA-N 0.000 claims 3
- KOEMCGGITQTPGG-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CC3)CC2)=C1 KOEMCGGITQTPGG-UHFFFAOYSA-N 0.000 claims 3
- IDLJJGGZDVBDSV-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C3CCN(C3)CC2)N=C1 IDLJJGGZDVBDSV-UHFFFAOYSA-N 0.000 claims 3
- DEDHFECZOZINJE-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C3CCCN(C3)CC2)N=C1 DEDHFECZOZINJE-UHFFFAOYSA-N 0.000 claims 3
- QQBOBWKKYBWQDP-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C3CCCN(CC3)CC2)N=C1 QQBOBWKKYBWQDP-UHFFFAOYSA-N 0.000 claims 3
- ZUQLXECGKJQGGY-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 ZUQLXECGKJQGGY-UHFFFAOYSA-N 0.000 claims 3
- GNYSTCYGKBWDSS-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 GNYSTCYGKBWDSS-UHFFFAOYSA-N 0.000 claims 3
- CSGLMXWLMUVABY-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 CSGLMXWLMUVABY-UHFFFAOYSA-N 0.000 claims 3
- CAKWVYFZQPIFNQ-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 CAKWVYFZQPIFNQ-UHFFFAOYSA-N 0.000 claims 3
- QFWWZJTZMALTNZ-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 QFWWZJTZMALTNZ-UHFFFAOYSA-N 0.000 claims 3
- PTJYCIBCCKPWGP-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 PTJYCIBCCKPWGP-UHFFFAOYSA-N 0.000 claims 3
- AQCCUDJASAFKCI-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 AQCCUDJASAFKCI-UHFFFAOYSA-N 0.000 claims 3
- QSOQQHIPRGWAHW-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 QSOQQHIPRGWAHW-UHFFFAOYSA-N 0.000 claims 3
- PATOATUNXZUKGT-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 PATOATUNXZUKGT-UHFFFAOYSA-N 0.000 claims 3
- VSQVEKVXLQLHSW-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 VSQVEKVXLQLHSW-UHFFFAOYSA-N 0.000 claims 3
- KMFLGPNBXRWLTJ-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 KMFLGPNBXRWLTJ-UHFFFAOYSA-N 0.000 claims 3
- BXUAAGLNFFJMCD-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 BXUAAGLNFFJMCD-UHFFFAOYSA-N 0.000 claims 3
- YNTABVZBZZBFRO-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC(F)(F)C1=CN=CC(N2C3CCN(C3)CC2)=C1 YNTABVZBZZBFRO-UHFFFAOYSA-N 0.000 claims 3
- SMUAMNUNHWKUJE-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC(F)(F)C1=CN=CC(N2C3CCCN(C3)CC2)=C1 SMUAMNUNHWKUJE-UHFFFAOYSA-N 0.000 claims 3
- PETKNFCTCMWSSD-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC(F)(F)C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 PETKNFCTCMWSSD-UHFFFAOYSA-N 0.000 claims 3
- MCWCWFDBPBHUBW-UHFFFAOYSA-N 4-[5-[2-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC(F)(F)C1=CC=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 MCWCWFDBPBHUBW-UHFFFAOYSA-N 0.000 claims 3
- FDAGKRXXAOODGQ-UHFFFAOYSA-N 4-[5-[2-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC(F)(F)C1=CC=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 FDAGKRXXAOODGQ-UHFFFAOYSA-N 0.000 claims 3
- NWBCJVUBKURKRL-UHFFFAOYSA-N 4-[5-[2-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC(F)(F)C1=CC=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 NWBCJVUBKURKRL-UHFFFAOYSA-N 0.000 claims 3
- MSWQAAKLFQYFIE-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC(F)(F)C1=CC=CC(C=2C=NC(=CC=2)N2C3CCN(C3)CC2)=C1 MSWQAAKLFQYFIE-UHFFFAOYSA-N 0.000 claims 3
- AHEYFDCFKXVFLU-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC(F)(F)C1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(C3)CC2)=C1 AHEYFDCFKXVFLU-UHFFFAOYSA-N 0.000 claims 3
- DNHRVUWYSJDDDL-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC(F)(F)C1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CC3)CC2)=C1 DNHRVUWYSJDDDL-UHFFFAOYSA-N 0.000 claims 3
- ORPYXBPUHKVYTI-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CCN(C3)CC2)=C1 ORPYXBPUHKVYTI-UHFFFAOYSA-N 0.000 claims 3
- DKTQCDYKSSTWAU-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(C3)CC2)=C1 DKTQCDYKSSTWAU-UHFFFAOYSA-N 0.000 claims 3
- PWUJVVXLLRPIOH-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CC3)CC2)=C1 PWUJVVXLLRPIOH-UHFFFAOYSA-N 0.000 claims 3
- QRUKHMGABXWXNB-UHFFFAOYSA-N 4-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CCN(C3)CC2)=C1 QRUKHMGABXWXNB-UHFFFAOYSA-N 0.000 claims 3
- SPSWHYZXUXBIEF-UHFFFAOYSA-N 4-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CCCN(C3)CC2)=C1 SPSWHYZXUXBIEF-UHFFFAOYSA-N 0.000 claims 3
- MVPJDIFWGXJIHG-UHFFFAOYSA-N 4-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 MVPJDIFWGXJIHG-UHFFFAOYSA-N 0.000 claims 3
- TVZNQVUXEBUBQC-UHFFFAOYSA-N 4-pyrazin-2-yl-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C1=CN=CC=N1 TVZNQVUXEBUBQC-UHFFFAOYSA-N 0.000 claims 3
- OBMPINFYFFMVQG-UHFFFAOYSA-N 4-pyrazin-2-yl-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C1=CN=CC=N1 OBMPINFYFFMVQG-UHFFFAOYSA-N 0.000 claims 3
- DCACCJZOIAGMHR-UHFFFAOYSA-N 4-pyrazin-2-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C1=CN=CC=N1 DCACCJZOIAGMHR-UHFFFAOYSA-N 0.000 claims 3
- SCYFOVZSDZGGNK-UHFFFAOYSA-N 4-pyridin-2-yl-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C1=CC=CC=N1 SCYFOVZSDZGGNK-UHFFFAOYSA-N 0.000 claims 3
- SHUHLBNAIWFCOD-UHFFFAOYSA-N 4-pyridin-2-yl-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C1=CC=CC=N1 SHUHLBNAIWFCOD-UHFFFAOYSA-N 0.000 claims 3
- GATSHDMHXNTLRV-UHFFFAOYSA-N 4-pyridin-2-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C1=CC=CC=N1 GATSHDMHXNTLRV-UHFFFAOYSA-N 0.000 claims 3
- BFLSVNMSHDCZEX-UHFFFAOYSA-N 4-pyridin-3-yl-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C1=CC=CN=C1 BFLSVNMSHDCZEX-UHFFFAOYSA-N 0.000 claims 3
- XWDAADAHKJPVRC-UHFFFAOYSA-N 4-pyridin-3-yl-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C1=CC=CN=C1 XWDAADAHKJPVRC-UHFFFAOYSA-N 0.000 claims 3
- XXXSOCVFCZJMLD-UHFFFAOYSA-N 4-pyridin-3-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C1=CC=CN=C1 XXXSOCVFCZJMLD-UHFFFAOYSA-N 0.000 claims 3
- UYYLURCEMVZEDK-UHFFFAOYSA-N 4-pyridin-4-yl-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C1=CC=NC=C1 UYYLURCEMVZEDK-UHFFFAOYSA-N 0.000 claims 3
- KXVYYZXJAXJZBE-UHFFFAOYSA-N 4-pyridin-4-yl-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C1=CC=NC=C1 KXVYYZXJAXJZBE-UHFFFAOYSA-N 0.000 claims 3
- GQCPBXKFJVXXOU-UHFFFAOYSA-N 4-pyridin-4-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C1=CC=NC=C1 GQCPBXKFJVXXOU-UHFFFAOYSA-N 0.000 claims 3
- PGSVFCYGRPBXGY-UHFFFAOYSA-N 4-pyrimidin-5-yl-1,4-diazabicyclo[3.2.1]octane Chemical compound C1CN(CC2)CC1N2C1=CN=CN=C1 PGSVFCYGRPBXGY-UHFFFAOYSA-N 0.000 claims 3
- CATCPXNWJFCILI-UHFFFAOYSA-N 4-pyrimidin-5-yl-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C1=CN=CN=C1 CATCPXNWJFCILI-UHFFFAOYSA-N 0.000 claims 3
- VWEIDIRZYNFHFQ-UHFFFAOYSA-N 4-pyrimidin-5-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CCC2CCN1CCN2C1=CN=CN=C1 VWEIDIRZYNFHFQ-UHFFFAOYSA-N 0.000 claims 3
- JUFJEWIVSQVZIF-UHFFFAOYSA-N 4-quinolin-3-yl-1,4-diazabicyclo[3.3.2]decane Chemical compound C1CN(CC2)CCCC1N2C1=CN=C(C=CC=C2)C2=C1 JUFJEWIVSQVZIF-UHFFFAOYSA-N 0.000 claims 3
- GIJLCSFCEHZQSX-UHFFFAOYSA-N 5-(1,4-diazabicyclo[3.2.1]octan-4-yl)pyridine-3-carbonitrile Chemical compound N#CC1=CN=CC(N2C3CCN(C3)CC2)=C1 GIJLCSFCEHZQSX-UHFFFAOYSA-N 0.000 claims 3
- LRMIIBSFVUAXQM-UHFFFAOYSA-N 5-(1,4-diazabicyclo[3.3.1]nonan-4-yl)pyridine-3-carbonitrile Chemical compound N#CC1=CN=CC(N2C3CCCN(C3)CC2)=C1 LRMIIBSFVUAXQM-UHFFFAOYSA-N 0.000 claims 3
- YKUMCNKAZPIFJD-UHFFFAOYSA-N 5-(1,4-diazabicyclo[3.3.2]decan-4-yl)pyridine-3-carbonitrile Chemical compound N#CC1=CN=CC(N2C3CCCN(CC3)CC2)=C1 YKUMCNKAZPIFJD-UHFFFAOYSA-N 0.000 claims 3
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 3
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 3
- 206010012289 Dementia Diseases 0.000 claims 3
- 150000001602 bicycloalkyls Chemical group 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- QXAXZLYCXYTILW-UHFFFAOYSA-N ethyl 5-(1,4-diazabicyclo[3.2.1]octan-4-yl)pyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(N2C3CCN(C3)CC2)=C1 QXAXZLYCXYTILW-UHFFFAOYSA-N 0.000 claims 3
- LTIDGJOYUJPYNL-UHFFFAOYSA-N ethyl 5-(1,4-diazabicyclo[3.3.1]nonan-4-yl)pyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(N2C3CCCN(C3)CC2)=C1 LTIDGJOYUJPYNL-UHFFFAOYSA-N 0.000 claims 3
- WFXILIYPEXBRSH-UHFFFAOYSA-N ethyl 5-(1,4-diazabicyclo[3.3.2]decan-4-yl)pyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(N2C3CCCN(CC3)CC2)=C1 WFXILIYPEXBRSH-UHFFFAOYSA-N 0.000 claims 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- NXJSCIXIOSMADJ-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound N1=CC(Br)=CC=C1N1C(C2)CCN2CC1 NXJSCIXIOSMADJ-UHFFFAOYSA-N 0.000 claims 2
- DJSVJNXUPNCAES-UHFFFAOYSA-N 4-(5-bromopyridin-3-yl)-1,4-diazabicyclo[3.2.1]octane Chemical compound BrC1=CN=CC(N2C3CCN(C3)CC2)=C1 DJSVJNXUPNCAES-UHFFFAOYSA-N 0.000 claims 2
- GQGPJKVWIGYSNG-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound N1=CC(Cl)=CC=C1N1C(C2)CCCN2CC1 GQGPJKVWIGYSNG-UHFFFAOYSA-N 0.000 claims 2
- ODYHRRHIWGYYMQ-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazabicyclo[3.3.1]nonane Chemical compound C1CCC2CN1CCN2C(C=1)=CN=CC=1C1=CC=CC=C1 ODYHRRHIWGYYMQ-UHFFFAOYSA-N 0.000 claims 2
- QLCTVCKMVZULBL-UHFFFAOYSA-N 4-[2-methyl-5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.2]decane Chemical compound CC1=NC=C(C(F)(F)F)C=C1N1C(CC2)CCCN2CC1 QLCTVCKMVZULBL-UHFFFAOYSA-N 0.000 claims 2
- RTTNCLLPAICZHA-UHFFFAOYSA-N 4-[3-(trifluoromethyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound FC(F)(F)C1=CC=CN=C1N1C(C2)CCCN2CC1 RTTNCLLPAICZHA-UHFFFAOYSA-N 0.000 claims 2
- STHVAVJZHYRAIC-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.1]nonane Chemical compound ClC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(C3)CC2)=C1 STHVAVJZHYRAIC-UHFFFAOYSA-N 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 208000028698 Cognitive impairment Diseases 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 229940125717 barbiturate Drugs 0.000 claims 2
- LPCWKMYWISGVSK-UHFFFAOYSA-N bicyclo[3.2.1]octane Chemical compound C1C2CCC1CCC2 LPCWKMYWISGVSK-UHFFFAOYSA-N 0.000 claims 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 206010013663 drug dependence Diseases 0.000 claims 2
- 206010015037 epilepsy Diseases 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 208000013403 hyperactivity Diseases 0.000 claims 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 230000009529 traumatic brain injury Effects 0.000 claims 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 1
- SNGIMSBTDWJXSK-UHFFFAOYSA-N 3-(1,4-diazabicyclo[3.1.1]heptan-4-yl)quinoline Chemical compound C1=CC=CC2=CC(N3CCN4CC3C4)=CN=C21 SNGIMSBTDWJXSK-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- SEROKWJYCMBMNV-UHFFFAOYSA-N 4-(3-bromophenyl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound BrC1=CC=CC(N2C3CN(C3)CC2)=C1 SEROKWJYCMBMNV-UHFFFAOYSA-N 0.000 claims 1
- IAZOEQQOFGUKSQ-UHFFFAOYSA-N 4-(3-bromophenyl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound BrC1=CC=CC(N2C3CCCN(CCC3)CC2)=C1 IAZOEQQOFGUKSQ-UHFFFAOYSA-N 0.000 claims 1
- FFLRDSAIYYOZMF-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound N1=CC(Br)=CC=C1N1C(C2)CN2CC1 FFLRDSAIYYOZMF-UHFFFAOYSA-N 0.000 claims 1
- QGIPWZDOYQJFRS-UHFFFAOYSA-N 4-(5-bromopyridin-2-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound N1=CC(Br)=CC=C1N1C(CCC2)CCCN2CC1 QGIPWZDOYQJFRS-UHFFFAOYSA-N 0.000 claims 1
- NFRDNTISCHERNQ-UHFFFAOYSA-N 4-(5-bromopyridin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound BrC1=CN=CC(N2C3CN(C3)CC2)=C1 NFRDNTISCHERNQ-UHFFFAOYSA-N 0.000 claims 1
- IDRMUPZBPIXIIO-UHFFFAOYSA-N 4-(5-bromopyridin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound BrC1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 IDRMUPZBPIXIIO-UHFFFAOYSA-N 0.000 claims 1
- DVAUUTMNSGNEKR-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound N1=CC(Cl)=CC=C1N1C(C2)CN2CC1 DVAUUTMNSGNEKR-UHFFFAOYSA-N 0.000 claims 1
- ICLUZMFAJXBWPU-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound N1=CC(Cl)=CC=C1N1C(CCC2)CCCN2CC1 ICLUZMFAJXBWPU-UHFFFAOYSA-N 0.000 claims 1
- KXRVVSCDCYJFJA-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound ClC1=CN=CC(N2C3CN(C3)CC2)=C1 KXRVVSCDCYJFJA-UHFFFAOYSA-N 0.000 claims 1
- HMKHYCRAGSYDGY-UHFFFAOYSA-N 4-(5-chloropyridin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound ClC1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 HMKHYCRAGSYDGY-UHFFFAOYSA-N 0.000 claims 1
- JHTFYWLOHCBAQL-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound COC1=CN=CC(N2C3CN(C3)CC2)=C1 JHTFYWLOHCBAQL-UHFFFAOYSA-N 0.000 claims 1
- MHUAOHUWXYXYHK-UHFFFAOYSA-N 4-(5-methoxypyridin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound COC1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 MHUAOHUWXYXYHK-UHFFFAOYSA-N 0.000 claims 1
- YSTAKVPJFKYLJH-UHFFFAOYSA-N 4-(5-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C(N=NC=1)=CC=1C1=CC=CC=C1 YSTAKVPJFKYLJH-UHFFFAOYSA-N 0.000 claims 1
- FNPXNIMZTLVYSN-UHFFFAOYSA-N 4-(5-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C(N=NC=1)=CC=1C1=CC=CC=C1 FNPXNIMZTLVYSN-UHFFFAOYSA-N 0.000 claims 1
- OEAKUEUFCYRRTJ-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C(C=1)=CN=CC=1C1=CC=CC=C1 OEAKUEUFCYRRTJ-UHFFFAOYSA-N 0.000 claims 1
- KPZDVKRXTZLVHW-UHFFFAOYSA-N 4-(5-phenylpyridin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C(C=1)=CN=CC=1C1=CC=CC=C1 KPZDVKRXTZLVHW-UHFFFAOYSA-N 0.000 claims 1
- FUJXZXPLYVOOOB-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound COC1=CC=CC(N2C3CN(C3)CC2)=N1 FUJXZXPLYVOOOB-UHFFFAOYSA-N 0.000 claims 1
- NMDGJVIKDURESY-UHFFFAOYSA-N 4-(6-methoxypyridin-2-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound COC1=CC=CC(N2C3CCCN(CCC3)CC2)=N1 NMDGJVIKDURESY-UHFFFAOYSA-N 0.000 claims 1
- HNCPYGCFYUQUBE-UHFFFAOYSA-N 4-(6-methylpyridin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=NC(C)=CC=C1N1C(C2)CN2CC1 HNCPYGCFYUQUBE-UHFFFAOYSA-N 0.000 claims 1
- FRSDCGTUTGCTPE-UHFFFAOYSA-N 4-(6-methylpyridin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=NC(C)=CC=C1N1C(CCC2)CCCN2CC1 FRSDCGTUTGCTPE-UHFFFAOYSA-N 0.000 claims 1
- RMZKAUGAGKJWCC-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C(N=N1)=CC=C1C1=CC=CC=C1 RMZKAUGAGKJWCC-UHFFFAOYSA-N 0.000 claims 1
- YEZBHORJGQSWBB-UHFFFAOYSA-N 4-(6-phenylpyridazin-3-yl)-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C(N=N1)=CC=C1C1=CC=CC=C1 YEZBHORJGQSWBB-UHFFFAOYSA-N 0.000 claims 1
- MXSGHQLCFQWGGA-UHFFFAOYSA-N 4-[2-methyl-5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound CC1=NC=C(C(F)(F)F)C=C1N1C(C2)CN2CC1 MXSGHQLCFQWGGA-UHFFFAOYSA-N 0.000 claims 1
- UJFVVKWTZCAPRO-UHFFFAOYSA-N 4-[2-methyl-5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.2.1]octane Chemical compound CC1=NC=C(C(F)(F)F)C=C1N1C(C2)CCN2CC1 UJFVVKWTZCAPRO-UHFFFAOYSA-N 0.000 claims 1
- PVXICUGFNHDZLY-UHFFFAOYSA-N 4-[2-methyl-5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound CC1=NC=C(C(F)(F)F)C=C1N1C(CCC2)CCCN2CC1 PVXICUGFNHDZLY-UHFFFAOYSA-N 0.000 claims 1
- MZYKPDMJSIQOTL-UHFFFAOYSA-N 4-[3-(trifluoromethyl)pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC(F)(F)C1=CC=CN=C1N1C(C2)CN2CC1 MZYKPDMJSIQOTL-UHFFFAOYSA-N 0.000 claims 1
- PJXNLLUJHYKNCL-UHFFFAOYSA-N 4-[3-(trifluoromethyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC(F)(F)C1=CC=CN=C1N1C(CCC2)CCCN2CC1 PJXNLLUJHYKNCL-UHFFFAOYSA-N 0.000 claims 1
- XMNPGVRWELMERG-UHFFFAOYSA-N 4-[5-(2,4-dichlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound ClC1=CC(Cl)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 XMNPGVRWELMERG-UHFFFAOYSA-N 0.000 claims 1
- IWFKITHVLUBRPA-UHFFFAOYSA-N 4-[5-(2,4-dichlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound ClC1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 IWFKITHVLUBRPA-UHFFFAOYSA-N 0.000 claims 1
- DVOOGRKGDJXSPM-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 DVOOGRKGDJXSPM-UHFFFAOYSA-N 0.000 claims 1
- YIWNDVZJICJRAP-UHFFFAOYSA-N 4-[5-(2-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 YIWNDVZJICJRAP-UHFFFAOYSA-N 0.000 claims 1
- HMLRFUBNWHEZGI-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 HMLRFUBNWHEZGI-UHFFFAOYSA-N 0.000 claims 1
- JDIDXYCULFNDLD-UHFFFAOYSA-N 4-[5-(2-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound COC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 JDIDXYCULFNDLD-UHFFFAOYSA-N 0.000 claims 1
- RSENQOLOFXUVLF-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound CC1=CC=CC=C1C1=CC=C(N2C3CN(C3)CC2)N=C1 RSENQOLOFXUVLF-UHFFFAOYSA-N 0.000 claims 1
- WGTZMFXXBNCSQI-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound CC1=CC=CC=C1C1=CC=C(N2C3CCCN(CCC3)CC2)N=C1 WGTZMFXXBNCSQI-UHFFFAOYSA-N 0.000 claims 1
- KBGGWOCEXMKNSL-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound CC1=CC=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 KBGGWOCEXMKNSL-UHFFFAOYSA-N 0.000 claims 1
- GNGRMOUXXHYRBY-UHFFFAOYSA-N 4-[5-(2-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound CC1=CC=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 GNGRMOUXXHYRBY-UHFFFAOYSA-N 0.000 claims 1
- ASSBWZVZVXVBLE-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound ClC1=CC=CC(C=2C=NC(=CC=2)N2C3CN(C3)CC2)=C1 ASSBWZVZVXVBLE-UHFFFAOYSA-N 0.000 claims 1
- SWXBFFUQLYGSSR-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound ClC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CCC3)CC2)=C1 SWXBFFUQLYGSSR-UHFFFAOYSA-N 0.000 claims 1
- CBIGMBHMBAMCKC-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound ClC1=CC=CC(C=2C=C(C=NC=2)N2C3CN(C3)CC2)=C1 CBIGMBHMBAMCKC-UHFFFAOYSA-N 0.000 claims 1
- KKXAFGUXBIJNEU-UHFFFAOYSA-N 4-[5-(3-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound ClC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CCC3)CC2)=C1 KKXAFGUXBIJNEU-UHFFFAOYSA-N 0.000 claims 1
- FXHQJMLCSWDOSH-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC1=CC=CC(C=2C=NC(=CC=2)N2C3CN(C3)CC2)=C1 FXHQJMLCSWDOSH-UHFFFAOYSA-N 0.000 claims 1
- NELUDQWGPMZZQM-UHFFFAOYSA-N 4-[5-(3-fluorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CCC3)CC2)=C1 NELUDQWGPMZZQM-UHFFFAOYSA-N 0.000 claims 1
- GAEGXIOHCDZXPP-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CN(C3)CC2)=C1 GAEGXIOHCDZXPP-UHFFFAOYSA-N 0.000 claims 1
- LAAPCLAZYNMYJF-UHFFFAOYSA-N 4-[5-(3-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound COC1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CCC3)CC2)=C1 LAAPCLAZYNMYJF-UHFFFAOYSA-N 0.000 claims 1
- BUBXYJURSUDVGW-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C3CN(C3)CC2)N=C1 BUBXYJURSUDVGW-UHFFFAOYSA-N 0.000 claims 1
- RWYFEYXZYZOSDI-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(Cl)=CC=C1C1=CC=C(N2C3CCCN(CCC3)CC2)N=C1 RWYFEYXZYZOSDI-UHFFFAOYSA-N 0.000 claims 1
- AQXGAPGHZXLVIX-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(Cl)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 AQXGAPGHZXLVIX-UHFFFAOYSA-N 0.000 claims 1
- VBTCLVIWIRGGJM-UHFFFAOYSA-N 4-[5-(4-chlorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(Cl)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 VBTCLVIWIRGGJM-UHFFFAOYSA-N 0.000 claims 1
- LFTIVEWWJMUSDC-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 LFTIVEWWJMUSDC-UHFFFAOYSA-N 0.000 claims 1
- FTNPOMWIWLYQQO-UHFFFAOYSA-N 4-[5-(4-fluorophenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(F)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 FTNPOMWIWLYQQO-UHFFFAOYSA-N 0.000 claims 1
- PYBKRFQSFWKXMF-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 PYBKRFQSFWKXMF-UHFFFAOYSA-N 0.000 claims 1
- GQXWYUPEMVLKLS-UHFFFAOYSA-N 4-[5-(4-methoxyphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(OC)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 GQXWYUPEMVLKLS-UHFFFAOYSA-N 0.000 claims 1
- UEDHRGJDCQFGIC-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 UEDHRGJDCQFGIC-UHFFFAOYSA-N 0.000 claims 1
- ROAUFBVXRHBIPF-UHFFFAOYSA-N 4-[5-(4-methylphenyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(C)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 ROAUFBVXRHBIPF-UHFFFAOYSA-N 0.000 claims 1
- WFRCLLGVOLFQGL-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC(F)(F)C1=CN=CC(N2C3CN(C3)CC2)=C1 WFRCLLGVOLFQGL-UHFFFAOYSA-N 0.000 claims 1
- DYRPJMXAVOSVGU-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC(F)(F)C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 DYRPJMXAVOSVGU-UHFFFAOYSA-N 0.000 claims 1
- KHQQTZNULMHUBO-UHFFFAOYSA-N 4-[5-[2-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC(F)(F)C1=CC=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 KHQQTZNULMHUBO-UHFFFAOYSA-N 0.000 claims 1
- DOJZKJRILMCCNL-UHFFFAOYSA-N 4-[5-[2-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC(F)(F)C1=CC=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 DOJZKJRILMCCNL-UHFFFAOYSA-N 0.000 claims 1
- XWOFLWOWRHXCKC-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC(F)(F)C1=CC=CC(C=2C=NC(=CC=2)N2C3CN(C3)CC2)=C1 XWOFLWOWRHXCKC-UHFFFAOYSA-N 0.000 claims 1
- MRLFNPXIHLATIU-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC(F)(F)C1=CC=CC(C=2C=NC(=CC=2)N2C3CCCN(CCC3)CC2)=C1 MRLFNPXIHLATIU-UHFFFAOYSA-N 0.000 claims 1
- KZTMISUSYXSNGD-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CN(C3)CC2)=C1 KZTMISUSYXSNGD-UHFFFAOYSA-N 0.000 claims 1
- ZOIBLFBFBXUGCT-UHFFFAOYSA-N 4-[5-[3-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound FC(F)(F)C1=CC=CC(C=2C=C(C=NC=2)N2C3CCCN(CCC3)CC2)=C1 ZOIBLFBFBXUGCT-UHFFFAOYSA-N 0.000 claims 1
- FDJIXGOVALQPEJ-UHFFFAOYSA-N 4-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CN(C3)CC2)=C1 FDJIXGOVALQPEJ-UHFFFAOYSA-N 0.000 claims 1
- LRUOJRRXBHNNJE-UHFFFAOYSA-N 4-[5-[4-(trifluoromethyl)phenyl]pyridin-3-yl]-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 LRUOJRRXBHNNJE-UHFFFAOYSA-N 0.000 claims 1
- VGVUVMOYUHUBSZ-UHFFFAOYSA-N 4-pyrazin-2-yl-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C1=CN=CC=N1 VGVUVMOYUHUBSZ-UHFFFAOYSA-N 0.000 claims 1
- VYDBCDDQNPDDMQ-UHFFFAOYSA-N 4-pyrazin-2-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C1=CN=CC=N1 VYDBCDDQNPDDMQ-UHFFFAOYSA-N 0.000 claims 1
- RXURLQMTLGELBL-UHFFFAOYSA-N 4-pyridin-2-yl-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C1=CC=CC=N1 RXURLQMTLGELBL-UHFFFAOYSA-N 0.000 claims 1
- IMSKHOPCDXZSFD-UHFFFAOYSA-N 4-pyridin-2-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C1=CC=CC=N1 IMSKHOPCDXZSFD-UHFFFAOYSA-N 0.000 claims 1
- XIIAQERFDCCXNV-UHFFFAOYSA-N 4-pyridin-3-yl-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C1=CC=CN=C1 XIIAQERFDCCXNV-UHFFFAOYSA-N 0.000 claims 1
- OWTNVOGLPJONED-UHFFFAOYSA-N 4-pyridin-3-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C1=CC=CN=C1 OWTNVOGLPJONED-UHFFFAOYSA-N 0.000 claims 1
- ADEDMBBXPDHUEN-UHFFFAOYSA-N 4-pyridin-4-yl-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C1=CC=NC=C1 ADEDMBBXPDHUEN-UHFFFAOYSA-N 0.000 claims 1
- GONOMSMWGOXOPM-UHFFFAOYSA-N 4-pyridin-4-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C1=CC=NC=C1 GONOMSMWGOXOPM-UHFFFAOYSA-N 0.000 claims 1
- IPEXQVDYKNICCV-UHFFFAOYSA-N 4-pyrimidin-5-yl-1,4-diazabicyclo[3.1.1]heptane Chemical compound C1C2CN1CCN2C1=CN=CN=C1 IPEXQVDYKNICCV-UHFFFAOYSA-N 0.000 claims 1
- ZEUQRDRUFTZING-UHFFFAOYSA-N 4-pyrimidin-5-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCC2CCCN1CCN2C1=CN=CN=C1 ZEUQRDRUFTZING-UHFFFAOYSA-N 0.000 claims 1
- MCCVPYUXILDFBD-UHFFFAOYSA-N 4-quinolin-3-yl-1,4-diazabicyclo[3.3.3]undecane Chemical compound C1CCN(CC2)CCCC1N2C1=CN=C(C=CC=C2)C2=C1 MCCVPYUXILDFBD-UHFFFAOYSA-N 0.000 claims 1
- KFNOHGQJEWHPMC-UHFFFAOYSA-N 5-(1,4-diazabicyclo[3.3.3]undecan-4-yl)pyridine-3-carbonitrile Chemical compound N#CC1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 KFNOHGQJEWHPMC-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 claims 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 206010003805 Autism Diseases 0.000 claims 1
- 208000020706 Autistic disease Diseases 0.000 claims 1
- 208000000412 Avitaminosis Diseases 0.000 claims 1
- 206010004716 Binge eating Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000032841 Bulimia Diseases 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000014094 Dystonic disease Diseases 0.000 claims 1
- 201000011240 Frontotemporal dementia Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 208000006264 Korsakoff syndrome Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000016285 Movement disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 208000000609 Pick Disease of the Brain Diseases 0.000 claims 1
- 208000028017 Psychotic disease Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 208000000323 Tourette Syndrome Diseases 0.000 claims 1
- 208000016620 Tourette disease Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 201000004810 Vascular dementia Diseases 0.000 claims 1
- 206010047139 Vasoconstriction Diseases 0.000 claims 1
- 206010047627 Vitamin deficiencies Diseases 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 230000007000 age related cognitive decline Effects 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 229910052785 arsenic Inorganic materials 0.000 claims 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims 1
- 229940049706 benzodiazepine Drugs 0.000 claims 1
- 150000001557 benzodiazepines Chemical class 0.000 claims 1
- WMRPOCDOMSNXCQ-UHFFFAOYSA-N bicyclo[3.3.2]decane Chemical compound C1CCC2CCCC1CC2 WMRPOCDOMSNXCQ-UHFFFAOYSA-N 0.000 claims 1
- 208000014679 binge eating disease Diseases 0.000 claims 1
- 235000009120 camo Nutrition 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 235000005607 chanvre indien Nutrition 0.000 claims 1
- 229960003920 cocaine Drugs 0.000 claims 1
- 230000001149 cognitive effect Effects 0.000 claims 1
- 230000002920 convulsive effect Effects 0.000 claims 1
- 201000003146 cystitis Diseases 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 230000006735 deficit Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 206010013932 dyslexia Diseases 0.000 claims 1
- 208000010118 dystonia Diseases 0.000 claims 1
- 206010014599 encephalitis Diseases 0.000 claims 1
- ONRKYFKRCPIEOL-UHFFFAOYSA-N ethyl 5-(1,4-diazabicyclo[3.1.1]heptan-4-yl)pyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(N2C3CN(C3)CC2)=C1 ONRKYFKRCPIEOL-UHFFFAOYSA-N 0.000 claims 1
- IXQZNNAQYIRUKK-UHFFFAOYSA-N ethyl 5-(1,4-diazabicyclo[3.3.3]undecan-4-yl)pyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(N2C3CCCN(CCC3)CC2)=C1 IXQZNNAQYIRUKK-UHFFFAOYSA-N 0.000 claims 1
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 1
- 210000004211 gastric acid Anatomy 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 239000011487 hemp Substances 0.000 claims 1
- 208000007386 hepatic encephalopathy Diseases 0.000 claims 1
- 208000003532 hypothyroidism Diseases 0.000 claims 1
- 230000002989 hypothyroidism Effects 0.000 claims 1
- 230000007574 infarction Effects 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
- 229910052753 mercury Inorganic materials 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000003387 muscular Effects 0.000 claims 1
- 229960002715 nicotine Drugs 0.000 claims 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229940005483 opioid analgesics Drugs 0.000 claims 1
- 208000019906 panic disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 208000028591 pheochromocytoma Diseases 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 208000009954 pyoderma gangrenosum Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- 208000019116 sleep disease Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 239000002951 street drug Substances 0.000 claims 1
- 235000019505 tobacco product Nutrition 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
- 230000025033 vasoconstriction Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40969402P | 2002-09-10 | 2002-09-10 | |
| PCT/IB2003/003795 WO2004024729A1 (en) | 2002-09-10 | 2003-08-29 | Diazabicyclic compounds useful in the treatment of cns and other disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504690A JP2006504690A (ja) | 2006-02-09 |
| JP2006504690A5 true JP2006504690A5 (enExample) | 2006-10-05 |
Family
ID=31993993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004535749A Withdrawn JP2006504690A (ja) | 2002-09-10 | 2003-08-29 | Ｃｎｓ及びその他の障害の治療に有用なジアザ二環式化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7442694B2 (enExample) |
| EP (1) | EP1551843A1 (enExample) |
| JP (1) | JP2006504690A (enExample) |
| AU (1) | AU2003255993A1 (enExample) |
| BR (1) | BR0314201A (enExample) |
| CA (1) | CA2498291C (enExample) |
| MX (1) | MXPA05002621A (enExample) |
| WO (1) | WO2004024729A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223753B2 (en) * | 2002-11-11 | 2007-05-29 | Neurosearch A/S | Diazabicyclic biaryl derivatives |
| ATE552236T1 (de) | 2003-01-14 | 2012-04-15 | Cytokinetics Inc | Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz |
| CA2554050A1 (en) | 2004-02-04 | 2005-08-18 | Neurosearch A/S | Diazabicyclic aryl derivatives as cholinergic receptor modulators |
| ES2522579T3 (es) | 2004-06-17 | 2014-11-17 | Cytokinetics, Inc. | Compuestos, composiciones y métodos |
| US7176222B2 (en) | 2004-07-27 | 2007-02-13 | Cytokinetics, Inc. | Syntheses of ureas |
| US7538223B2 (en) | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
| ES2419007T3 (es) | 2005-12-15 | 2013-08-19 | Cytokinetics, Inc. | Ciertas entidades químicas, composiciones y procedimientos |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| WO2007078815A2 (en) | 2005-12-16 | 2007-07-12 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2007078839A2 (en) | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
| AU2007267177A1 (en) | 2006-05-30 | 2007-12-06 | Neurosearch A/S | Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| US7935695B2 (en) * | 2007-08-17 | 2011-05-03 | Neurosearch A/S | 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands |
| EP2190846A1 (en) * | 2007-08-17 | 2010-06-02 | Neurosearch A/S | 1,4-diaza-bicycl0(3.2.2)n0nyl pyrimidinyl derivatives useful as nicotinic acetylcholine- receptor ligands |
| DE102007053771A1 (de) * | 2007-11-12 | 2009-05-14 | Merck Patent Gmbh | Organische Elektrolumineszenzvorrichtungen |
| EP2209783B8 (en) | 2007-11-14 | 2016-06-01 | Saniona A/S | Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| US20100305108A1 (en) * | 2007-11-14 | 2010-12-02 | Neurosearch A/S | Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| EP2209782A1 (en) * | 2007-11-14 | 2010-07-28 | NeuroSearch A/S | Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| US20110118268A1 (en) | 2008-03-11 | 2011-05-19 | Dan Peters | Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators |
| US20110257161A1 (en) * | 2008-12-04 | 2011-10-20 | Neurosearch A/S | Novel diaza-bicyclononyl-phenyl derivatives and their medical use |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| CA3230630A1 (en) | 2021-09-08 | 2023-03-16 | Curtis SWIFT | Analytical methods of assessing cytisine purity |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4571396A (en) * | 1984-04-16 | 1986-02-18 | Warner-Lambert Company | Antibacterial agents |
| IN166416B (enExample) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| ZA877471B (en) * | 1986-10-08 | 1988-04-05 | Bristol-Myers Company | 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents |
| DE3711193A1 (de) * | 1987-04-02 | 1988-10-13 | Bayer Ag | 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| DE4210941A1 (de) * | 1992-04-02 | 1993-10-07 | Bayer Ag | Neue 9-Fluor-7.oxo-7H-pyrido[1,2,3-d,e][1,4]benzoxacin-6-carbonsäuren und -ester |
| GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| WO2000006575A2 (en) * | 1998-07-28 | 2000-02-10 | Smithkline Beecham Plc | Azabicyclic compounds |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| FR2804430B1 (fr) * | 2000-01-28 | 2002-03-22 | Sanofi Synthelabo | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
-
2003
- 2003-08-29 CA CA002498291A patent/CA2498291C/en not_active Expired - Fee Related
- 2003-08-29 WO PCT/IB2003/003795 patent/WO2004024729A1/en not_active Ceased
- 2003-08-29 EP EP03795129A patent/EP1551843A1/en not_active Withdrawn
- 2003-08-29 MX MXPA05002621A patent/MXPA05002621A/es unknown
- 2003-08-29 AU AU2003255993A patent/AU2003255993A1/en not_active Abandoned
- 2003-08-29 BR BR0314201-9A patent/BR0314201A/pt not_active IP Right Cessation
- 2003-08-29 JP JP2004535749A patent/JP2006504690A/ja not_active Withdrawn
- 2003-09-08 US US10/657,738 patent/US7442694B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006504690A5 (enExample) | ||
| KR101781723B1 (ko) | 헤테로방향족 화합물, 및 도파민 d1 리간드로서 이의 용도 | |
| JP2019509274A5 (enExample) | ||
| IL263912A (en) | 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases | |
| IL271290B2 (en) | Dihydro-pyrrolo-pyridine derivatives | |
| JP2023518838A5 (enExample) | ||
| JP2021054843A (ja) | トロポミオシン関連キナーゼ（ｔｒｋ）阻害剤 | |
| CA2577525A1 (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
| US7442694B2 (en) | Diazabicyclic compounds useful in the treatment of CNS and other disorders | |
| EP2958915A1 (en) | Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders | |
| EA030410B1 (ru) | Замещенные конденсированные гетероциклы в качестве модуляторов gpr119 для лечения диабета, ожирения, дислипидемии и связанных нарушений | |
| DE69713255T2 (de) | Pharmazeutische Pyridin-Derivate, ihre Herstellungsverfahren und Zwischenprodukte dafür | |
| EP3380471A1 (en) | Comt inhibiting methods and compositions | |
| JP2020520925A5 (enExample) | ||
| KR102000382B1 (ko) | 신규 시클로프로파벤조푸라닐 피리도피라진디온 | |
| CA2516514A1 (en) | Arylvinylazacycloalkane compounds and methods of preparation and use thereof | |
| JP2006519868A5 (enExample) | ||
| JP4285994B2 (ja) | 複素環化合物及びそれを有効成分とする脳機能改善剤 | |
| HRP20150707T1 (hr) | Novi derivati (heterocikal/kondenzirani piperidin)-(piperazinil)-1-alkanon ili (heterocikal/kondenzirani pirolidin)-(piperazinil)-1-alkanon, i njihova uporaba kao inhibitora p75 | |
| JP2022519639A5 (enExample) | ||
| IE841047L (en) | 5-acyl-2-(1h)-pyridinones. | |
| CA2565689A1 (en) | Substituted pyrrolidine-2-ones | |
| JP2004527562A5 (enExample) | ||
| JP4870164B2 (ja) | ナフチリジン誘導体 | |
| RU2008115034A (ru) | Производные тиазоло[4,5-с]пиридина в качестве антагонистов рецепторов mglur5 |